Neisseria gonorrhoeae employs two protein inhibitors to evade killing by human lysozyme.

Ragland, Stephanie A; Humbert, MarÎ¯a V; Christodoulides, Myron; Criss, Alison K

Ragland, Stephanie A; Humbert, MarÎ¯a V; Christodoulides, Myron; Criss, Alison K.

Afiliación

Ragland SA; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia, United States of America.
Humbert MV; Neisseria Research, Molecular Microbiology, Academic Unit of Clinical and Experimental Sciences, Sir Henry Wellcome Laboratories, University of Southampton Faculty of Medicine, Southampton, United Kingdom.
Christodoulides M; Neisseria Research, Molecular Microbiology, Academic Unit of Clinical and Experimental Sciences, Sir Henry Wellcome Laboratories, University of Southampton Faculty of Medicine, Southampton, United Kingdom.
Criss AK; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia, United States of America.

PLoS Pathog ; 14(7): e1007080, 2018 07.

Article en En | MEDLINE | ID: mdl-29975775

Asunto(s)

Proteínas Bacterianas/inmunología; Interacciones Huésped-Patógeno/inmunología; Neisseria gonorrhoeae/patogenicidad; Gonorrea/inmunología; Humanos; Muramidasa/antagonistas & inhibidores; Muramidasa/inmunología; Neisseria gonorrhoeae/inmunología

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas Bacterianas / Interacciones Huésped-Patógeno / Neisseria gonorrhoeae Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: PLoS Pathog Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google